Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ERYTHROMYCIN Cause Intentional product use issue? 34 Reports in FDA Database

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

According to the FDA Adverse Event Reporting System (FAERS), 34 reports of Intentional product use issue have been filed in association with ERYTHROMYCIN (Erythromycin). This represents 0.5% of all adverse event reports for ERYTHROMYCIN.

34
Reports of Intentional product use issue with ERYTHROMYCIN
0.5%
of all ERYTHROMYCIN reports
25
Deaths
27
Hospitalizations

How Dangerous Is Intentional product use issue From ERYTHROMYCIN?

Of the 34 reports, 25 (73.5%) resulted in death, 27 (79.4%) required hospitalization, and 25 (73.5%) were considered life-threatening.

Is Intentional product use issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ERYTHROMYCIN. However, 34 reports have been filed with the FAERS database.

What Other Side Effects Does ERYTHROMYCIN Cause?

Drug hypersensitivity (3,813) Nausea (560) Drug ineffective (502) Vomiting (497) Rash (471) Hypersensitivity (401) Diarrhoea (378) Urticaria (361) Dyspnoea (344) Fatigue (344)

What Other Drugs Cause Intentional product use issue?

INFLIXIMAB (11,028) RITUXIMAB (9,602) INFLIXIMAB-DYYB (7,549) TOCILIZUMAB (5,078) METHOTREXATE (4,087) PREDNISONE (3,961) ABATACEPT (3,693) ADALIMUMAB (3,557) NIVOLUMAB (3,297) LEFLUNOMIDE (3,280)

Which ERYTHROMYCIN Alternatives Have Lower Intentional product use issue Risk?

ERYTHROMYCIN vs ERYTHROMYCIN ETHYLSUCCINATE ERYTHROMYCIN vs ERYTHROMYCIN LACTOBIONATE ERYTHROMYCIN vs ERYTHROPOIETIN ERYTHROMYCIN vs ESCHERICHIA COLI ERYTHROMYCIN vs ESCITALOPRAM

Related Pages

ERYTHROMYCIN Full Profile All Intentional product use issue Reports All Drugs Causing Intentional product use issue ERYTHROMYCIN Demographics